Back The First Patient
Chapters (68)
  1. THE FIRST PATIENT
  2. ACKNOWLEDGMENTS
  3. CHAPTER 1
  4. CHAPTER 2
  5. CHAPTER 3
  6. CHAPTER 4
  7. CHAPTER 5
  8. CHAPTER 6
  9. CHAPTER 7
  10. CHAPTER 8
  11. CHAPTER 9
  12. CHAPTER 10
  13. CHAPTER 11
  14. CHAPTER 12
  15. CHAPTER 13
  16. CHAPTER 14
  17. CHAPTER 15
  18. CHAPTER 16
  19. CHAPTER 17
  20. CHAPTER 18
  21. CHAPTER 19
  22. CHAPTER 20
  23. CHAPTER 21
  24. CHAPTER 22
  25. CHAPTER 23
  26. CHAPTER 24
  27. CHAPTER 25
  28. CHAPTER 26
  29. CHAPTER 27
  30. CHAPTER 28
  31. CHAPTER 29
  32. CHAPTER 30
  33. CHAPTER 31
  34. CHAPTER 32
  35. CHAPTER 33
  36. CHAPTER 34
  37. CHAPTER 35
  38. CHAPTER 36
  39. CHAPTER 37
  40. CHAPTER 38
  41. CHAPTER 39
  42. CHAPTER 40
  43. CHAPTER 41
  44. CHAPTER 42
  45. CHAPTER 43
  46. CHAPTER 44
  47. CHAPTER 45
  48. CHAPTER 46
  49. CHAPTER 47
  50. CHAPTER 48
  51. CHAPTER 49
  52. CHAPTER 50
  53. CHAPTER 51
  54. CHAPTER 52
  55. CHAPTER 53
  56. CHAPTER 54
  57. CHAPTER 55
  58. CHAPTER 56
  59. CHAPTER 57
  60. CHAPTER 58
  61. CHAPTER 59
  62. CHAPTER 60
  63. CHAPTER 61
  64. CHAPTER 62
  65. CHAPTER 63
  66. CHAPTER 64
  67. CHAPTER 65
  68. EPILOGUE

Gabe inched around the corner and peered down the corridor. At the end were two more doors, identical to the others. The right one was closed and the left one open. Pressed against the wall, every muscle tensed, he moved ahead. If someone came through the doors behind him now, there would be no retreat and, in all likelihood, no meeting with Ferendelli. Still, he had to see.

". . . This slide is a photo taken two months after the subjects were dosed with ten micrograms of fullerenes coated with antibodies specifically coded to hypothalamus neuroprotein. Administration in this subject was oral, but the results for intravenous and aerosolized fullerene administration were virtually the same. As you can see, there has been virtually no change in the location and concentration of immunofluorescence, even after thirty days. When these little fellows attach, they stay pretty well attached, although there is a very gradual leeching out."

Gabe thought the line about the "little fellows" and the way Rosenberg delivered it might have engendered at least a chuckle or two, but the assemblage remained stonily silent.

Five more feet.

Gabe was just a few steps from the closed door now. Through the glass he could see seven white-coated scientists—five men and two women—their backs to him, standing shoulder to shoulder at the far end of a carpeted room that was about a twenty-five-foot square—probably a conference room with the chairs removed.

Turn around and leave! Leave while you have the chance!

A slide was being projected on a screen before the small gathering. From what Gabe could see, the image was a cross section of brain, with the jade green glow of an immunofluorescent marker dye scattered over an area that apparently was the hypothalamus. At his very sharpest in neuroanatomy, which would have been a few minutes after finishing the course in med school, he could have easily identified the structures in the brain slice. Now, though, those days were long past and he would have to take Dr. Rosenberg's word.

A grainy slide with fluorescent marker was hardly the real living brains without bodies that the security guards had talked about. Gabe inched closer. At that moment, as if on cue, one of the scientists at the center of the line stepped back, turned to her left, and coughed deeply several times.

Through the opening she had created, Gabe saw three large glass cylinders, four feet high and a foot in diameter. They were filled to near the top with a translucent golden liquid—serum or some other form of nutrient, he guessed—which was being aerated by a bubbler built into the base, the source of the mechanical hum. A large number of monitoring wires snaked over the lips of each cylinder, connecting outside them with elaborate monitoring equipment, at least one of which was an EEG—an electroencephalogram—that was showing continuous brain-wave activity.